格雷夫斯病抗甲状腺治疗后对促甲状腺激素释放激素的反应、血清甲状腺激素浓度及自身免疫血清标志物 - Suppr

Suppr

超能文献

Response to TRH, serum thyroid hormone concentration, and serum markers of autoimmunity after antithyroid therapy in Graves' disease.

作者信息

Lamberg B A, Aro A, Saarinen P, Tötterman T, Mäkinen T

出版信息

J Endocrinol Invest. 1978 Jan;1(1):9-16. doi: 10.1007/BF03346765.

DOI:10.1007/BF03346765

PMID:90688

Abstract

摘要

相似文献

Response to TRH, serum thyroid hormone concentration, and serum markers of autoimmunity after antithyroid therapy in Graves' disease.格雷夫斯病抗甲状腺治疗后对促甲状腺激素释放激素的反应、血清甲状腺激素浓度及自身免疫血清标志物

J Endocrinol Invest. 1978 Jan;1(1):9-16. doi: 10.1007/BF03346765.

Are pituitary and thyroid function tests useful for the monitoring of antithyroid drug treatment and the post therapeutic control of Graves' disease?垂体和甲状腺功能检查对监测抗甲状腺药物治疗及Graves病治疗后的控制是否有用？

Horm Res. 1987;26(1-4):137-45. doi: 10.1159/000180693.

Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.既往接受抗甲状腺药物治疗的格雷夫斯病甲状腺功能正常患者的垂体-甲状腺调节。

J Clin Endocrinol Metab. 1976 Aug;43(2):419-27. doi: 10.1210/jcem-43-2-419.

Thyrotropin-releasing hormone testing during antithyroid drug treatment of Graves' disease as an indicator of remission.在格雷夫斯病抗甲状腺药物治疗期间进行促甲状腺激素释放激素检测作为缓解指标

J Clin Endocrinol Metab. 1985 Dec;61(6):1100-4. doi: 10.1210/jcem-61-6-1100.

Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.尽管促甲状腺激素结合抑制性免疫球蛋白检测结果迅速转阴，但仍存在持续性格雷夫斯甲亢：一例报告

J Med Case Rep. 2017 Feb 6;11(1):32. doi: 10.1186/s13256-017-1214-6.

Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.促甲状腺激素释放激素对血清甲状腺激素的影响：一项关于未经治疗及已治疗的格雷夫斯病和亚急性甲状腺炎患者的研究。

J Clin Endocrinol Metab. 1995 Jul;80(7):2173-7. doi: 10.1210/jcem.80.7.7608274.

Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.血清促甲状腺激素（TSH）水平持续受到抑制，可能归因于促甲状腺激素受体抗体活性、甲状腺毒症的严重程度以及接受治疗的甲状腺功能正常的格雷夫斯病患者甲状腺激素恢复所需的时间。

Thyroid. 2006 Dec;16(12):1251-7. doi: 10.1089/thy.2006.16.1251.

Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.慢性碘给药对既往因格雷夫斯甲亢接受抗甲状腺药物治疗的甲状腺功能正常受试者甲状腺状态的影响。

J Clin Endocrinol Metab. 1993 Apr;76(4):928-32. doi: 10.1210/jcem.76.4.7682562.

Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.格雷夫斯病抗甲状腺药物治疗过程中血清促甲状腺素结合抑制性抗体与促甲状腺抗体变化的差异。

Thyroid. 1999 Aug;9(8):769-73. doi: 10.1089/thy.1999.9.769.

Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease?格雷夫斯病病程中促甲状腺素受体抗体（TSI）的测定。这是该疾病缓解和持续存在的可靠指标吗？

J Endocrinol Invest. 1978 Apr;1(2):155-61. doi: 10.1007/BF03350364.

引用本文的文献

Spontaneous hypothyroidism after antithyroid treatment of hyperthyroid Graves' disease.甲状腺功能亢进症Graves病抗甲状腺治疗后发生的自发性甲状腺功能减退症。

J Endocrinol Invest. 1981 Oct-Dec;4(4):399-402. doi: 10.1007/BF03348302.

本文引用的文献

Thyroid-suppression test in the prognosis of hyperthyroidism treated by antithyroid drugs.甲状腺抑制试验在抗甲状腺药物治疗的甲状腺功能亢进症预后中的应用

N Engl J Med. 1960 Jun 16;262:1228-9. doi: 10.1056/NEJM196006162622406.

Studies of thyroid function and the peripheral metabolism of I 131-labeled thyroxine in patients with treated Graves disease.对已接受治疗的格雷夫斯病患者的甲状腺功能及131I标记甲状腺素的外周代谢研究。

J Clin Invest. 1958 Nov;37(11):1603-14. doi: 10.1172/JCI103753.

A new and simple test for hyperthyroidism employing L-triiodothyronine and the twenty-four hour I-131 uptake method.一种采用L-三碘甲状腺原氨酸和24小时I-131摄取法的新型简易甲状腺功能亢进症检测方法。

Bull N Y Acad Med. 1955 Feb;31(2):137-45.

Long-acting thyroid stimulator (LATS) in toxic nodular goitre, toxic adenoma and Graves' disease.毒性结节性甲状腺肿、毒性腺瘤及格雷夫斯病中的长效甲状腺刺激素（LATS）

Acta Endocrinol (Copenh). 1969 Oct;62(2):199-209. doi: 10.1530/acta.0.0620199.

Methodological study of the radioimmunoassay of human thyrotrophin.人促甲状腺素放射免疫测定法的方法学研究

Acta Endocrinol (Copenh). 1972 Sep;71(1):24-36. doi: 10.1530/acta.0.0710024.

Unresponsiveness to thyrotropin-releasing hormone (TRH) in treated Graves' hyperthyroidism and in euthyroid Graves' disease.治疗后Graves病甲亢患者及Graves病甲状腺功能正常患者对促甲状腺激素释放激素（TRH）无反应。

J Clin Endocrinol Metab. 1974 Apr;38(4):531-8. doi: 10.1210/jcem-38-4-531.

Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.格雷夫斯眼病患者下丘脑-垂体-甲状腺轴的异常。

J Clin Endocrinol Metab. 1973 Dec;37(6):955-67. doi: 10.1210/jcem-37-6-955.

Response to thyrotropin-releasing hormone compared with thyroid suppression tests in euthyroid Graves' disease.与甲状腺抑制试验相比，正常甲状腺功能的格雷夫斯病患者对促甲状腺激素释放激素的反应

Metabolism. 1973 Nov;23(2):1357-65. doi: 10.1016/0026-0495(73)90251-5.

Recurrence of hyperthyroidism shortly after return of normal suppressibility by triiodothyronine.三碘甲状腺原氨酸抑制试验恢复正常抑制能力后不久甲状腺功能亢进复发。

Br Med J. 1970 Aug 8;3(5718):327. doi: 10.1136/bmj.3.5718.327.

Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.甲状腺毒症抗甲状腺药物治疗长期疗效的预测

J Clin Endocrinol Metab. 1970 Apr;30(4):540-3. doi: 10.1210/jcem-30-4-540.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验